Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy

PHASE3CompletedINTERVENTIONAL
Enrollment

261

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

May 31, 2013

Conditions
Hypertension, Pregnancy Induced
Interventions
DRUG

Hydralazine

Patients with an hypertensive crisis during pregnancy will receive 5mg IV every 15 minutes until high blood pressure is controlled (Maximum number of doses: 3).

DRUG

Labetalol

Patients with an hypertensive crisis during pregnancy will receive 20 mg of Labetalol IV. After 15 minutes if the crisis continue, 40 mg IV. After 15 minutes if the crisis continue, 80 mg IV. Then, if the crisis continue, 80 mg IV every 15 minutes (maximum dose: 300 mg IV in total).

Trial Locations (1)

Unknown

Saint Thomas Maternity Hospital, Panama City

All Listed Sponsors
lead

Saint Thomas Hospital, Panama

OTHER

NCT01538875 - Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy | Biotech Hunter | Biotech Hunter